PTC Therapeutics, Inc. (PTCT)
66.83
-1.17
(-1.72%)
USD |
NASDAQ |
Sep 18, 11:27
PTC Therapeutics Price : 66.83 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 68.84 | 68.84 | 67.22 | 68.00 | 1.115M |
| Sep 16, 2026 | 65.99 | 67.90 | 65.80 | 67.59 | 1.398M |
| Sep 15, 2026 | 66.51 | 66.54 | 65.06 | 65.65 | 1.034M |
| Sep 14, 2026 | 67.09 | 67.99 | 65.91 | 66.48 | 1.019M |
| Sep 11, 2026 | 67.80 | 68.48 | 65.91 | 66.06 | 792890.0 |
| Sep 10, 2026 | 66.84 | 67.78 | 66.47 | 67.37 | 1.013M |
| Sep 09, 2026 | 68.08 | 68.84 | 67.50 | 67.57 | 1.067M |
| Sep 08, 2026 | 67.81 | 70.08 | 67.48 | 68.81 | 1.118M |
| Sep 04, 2026 | 70.62 | 71.40 | 69.26 | 69.30 | 673540.0 |
| Sep 03, 2026 | 71.76 | 71.97 | 70.55 | 71.40 | 654522.0 |
| Sep 02, 2026 | 71.15 | 72.68 | 69.84 | 71.79 | 902585.0 |
| Sep 01, 2026 | 69.42 | 70.84 | 69.05 | 70.56 | 691015.0 |
| Aug 31, 2026 | 69.98 | 70.42 | 68.76 | 69.54 | 841097.0 |
| Aug 28, 2026 | 71.08 | 71.49 | 69.61 | 70.09 | 692675.0 |
| Aug 27, 2026 | 72.11 | 72.66 | 70.91 | 71.81 | 746331.0 |
| Aug 26, 2026 | 73.18 | 73.52 | 71.81 | 72.69 | 533668.0 |
| Aug 25, 2026 | 71.69 | 73.47 | 71.69 | 73.47 | 624464.0 |
| Aug 24, 2026 | 69.67 | 71.45 | 68.02 | 71.06 | 897682.0 |
| Aug 21, 2026 | 70.54 | 71.36 | 69.79 | 69.82 | 674739.0 |
| Aug 20, 2026 | 73.05 | 73.56 | 70.46 | 70.52 | 802507.0 |
| Aug 19, 2026 | 73.72 | 74.02 | 72.22 | 73.67 | 1.515M |
| Aug 18, 2026 | 72.86 | 74.03 | 72.22 | 72.63 | 731633.0 |
| Aug 17, 2026 | 71.70 | 73.02 | 71.24 | 72.88 | 985769.0 |
| Aug 14, 2026 | 71.58 | 72.13 | 70.85 | 71.70 | 564331.0 |
| Aug 13, 2026 | 73.14 | 73.34 | 71.69 | 71.97 | 697348.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 217.72 |
| BioMarin Pharmaceutical, Inc. | 64.78 |
| Arcturus Therapeutics Holdings, Inc. | 16.79 |
| ACADIA Pharmaceuticals, Inc. | 27.17 |
| Alnylam Pharmaceuticals, Inc. | 243.80 |
Price Related Metrics
| PS Ratio | 5.670 |
| Earnings Yield | -0.89% |
| Market Cap | 5.569B |
| Operating PE Ratio | 49.00 |